Michel Mourad - Concepedia

Author

Michel Mourad

Also Known As

FAROUK A. MOURAD, M.D.; MOSTAFA A. HAMAD, M.D., M Mourad, M. Mourad, MICHEL MOURAD, Manal Mourad, Michel Mourad, Mourad, Michel, Moussa Mourad

208

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

UCLouvain Cliniques Universitaires Saint-Luc KU Leuven Ghent University Hospital Heidelberg University

About

Michel Mourad is an author at UCLouvain specializing in medicine, transplantation, and kidney transplant.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	1.6K
2	Health Sciences	3	3	69
3	Allergy	2	2	203
4	Engineering	1	1	22
5	Natural Sciences	1	1	17

Michel Mourad

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference Pierre Wallemacq, Victor W. Armstrong, Merçè Brunet, Therapeutic Drug Monitoring Uniform DoseSolid Organ TransplantationTransplantation MedicineSurgeryPharmacotherapy	2009	453
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients Vincent Haufroid, Michel Mourad, Val rie Van Kerckhove, Pharmacogenetics Specific PolymorphismTransplantationKidney TransplantTrough Blood LevelsMedicine	2004	444
Minimally Invasive Video‐assisted Thyroidectomy: Multiinstitutional Experience Paolo Miccoli, Rocco Bellantone, Michel Mourad, World Journal of Surgery	2002	228
Correlation of Mycophenolic Acid Pharmacokinetic Parameters with Side Effects in Kidney Transplant Patients Treated with Mycophenolate Mofetil Michel Mourad, Jacques Malaise, Djamila Chaïb Eddour, Clinical Chemistry	2001	190
Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes Nathalie Demotte, Vincent Stroobant, Pierre J. Courtoy, Immunity Tumor ImmunologyCancer ImmunosurveillanceAutoimmune DiseaseAllergyCd8 Reverses Anergy	2008	186
CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study Vincent Haufroid, Pierre Wallemacq, V. VanKerckhove, American Journal of Transplantation	2006	181
Effect of a New Functional<i>CYP3A4</i>Polymorphism on Calcineurin Inhibitors‘ Dose Requirements and Trough Blood Levels in Stable Renal Transplant Patients Laure Elens, Ron HN van Schaik, Nadtha Panin, Pharmacogenomics	2011	151
Sirolimus and Tacrolimus Trough Concentrations and Dose Requirements after Kidney Transplantation in Relation to CYP3A5 and MDR1 Polymorphisms and Steroids Michel Mourad, Georges Mourad, Pierre Wallemacq, Transplantation	2005	114
The place of liver transplantation in Caroli's disease and syndrome Laurent De Kerckhove, Martine De Meyer, Catherine Verbaandert, Transplant International	2006	112
Pharmacokinetic Basis for the Efficient and Safe Use of Low-Dose Mycophenolate Mofetil in Combination with Tacrolimus in Kidney Transplantation Michel Mourad, Jacques Malaise, Djamila Chaïb Eddour, Clinical Chemistry	2001	110

Page 1